Shakirova, V.; Markelova, M.; Davidyuk, Y.; Stott-Marshall, R.J.; Foster, T.L.; Khaiboullina, S.; Rizvanov, A.; Martynova, E.
Rosuvastatin as a Supplemental Treatment for the Clinical Symptoms of Nephropathia Epidemica: A Pilot Clinical Study. Viruses 2024, 16, 306.
https://doi.org/10.3390/v16020306
AMA Style
Shakirova V, Markelova M, Davidyuk Y, Stott-Marshall RJ, Foster TL, Khaiboullina S, Rizvanov A, Martynova E.
Rosuvastatin as a Supplemental Treatment for the Clinical Symptoms of Nephropathia Epidemica: A Pilot Clinical Study. Viruses. 2024; 16(2):306.
https://doi.org/10.3390/v16020306
Chicago/Turabian Style
Shakirova, Venera, Maria Markelova, Yuriy Davidyuk, Robert J. Stott-Marshall, Toshana L. Foster, Svetlana Khaiboullina, Albert Rizvanov, and Ekaterina Martynova.
2024. "Rosuvastatin as a Supplemental Treatment for the Clinical Symptoms of Nephropathia Epidemica: A Pilot Clinical Study" Viruses 16, no. 2: 306.
https://doi.org/10.3390/v16020306
APA Style
Shakirova, V., Markelova, M., Davidyuk, Y., Stott-Marshall, R. J., Foster, T. L., Khaiboullina, S., Rizvanov, A., & Martynova, E.
(2024). Rosuvastatin as a Supplemental Treatment for the Clinical Symptoms of Nephropathia Epidemica: A Pilot Clinical Study. Viruses, 16(2), 306.
https://doi.org/10.3390/v16020306
